For example, high DR4 expression has been shown to be associated with worse disease-free survival, worse overall survival and shorter time to recurrence in colon cancer [6], whereas DR4 expression did not impact patient survival in lung, cervical and ovarian cancers [7], [44], [45]. Here, TNFRSF10A is linked to malignant colon neoplasm.